These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30410349)
1. NFATC2 is a novel therapeutic target for colorectal cancer stem cells. Lang T; Ding X; Kong L; Zhou X; Zhang Z; Ju H; Ding S Onco Targets Ther; 2018; 11():6911-6924. PubMed ID: 30410349 [TBL] [Abstract][Full Text] [Related]
2. SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1. Tian C; Lang T; Qiu J; Han K; Zhou L; Min D; Zhang Z; Qi D Cancer Cell Int; 2020 Dec; 20(1):579. PubMed ID: 33292299 [TBL] [Abstract][Full Text] [Related]
3. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway. Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation. Bhatlekar S; Viswanathan V; Fields JZ; Boman BM J Cell Physiol; 2018 Feb; 233(2):727-735. PubMed ID: 28464221 [TBL] [Abstract][Full Text] [Related]
5. miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway. Zhang H; Lang TY; Zou DL; Zhou L; Lou M; Liu JS; Li YZ; Ding DY; Li YC; Zhang N; Zheng XD; Zeng XH; Zhou Q; Li L Onco Targets Ther; 2019; 12():11691-11700. PubMed ID: 32021247 [TBL] [Abstract][Full Text] [Related]
6. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Ouyang S; Zhou X; Chen Z; Wang M; Zheng X; Xie M Cancer Cell Int; 2019; 19():72. PubMed ID: 30962766 [TBL] [Abstract][Full Text] [Related]
7. CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway. Dong W; Cao Z; Pang Y; Feng T; Tian H Onco Targets Ther; 2019; 12():9041-9051. PubMed ID: 31802911 [TBL] [Abstract][Full Text] [Related]
8. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells. Li Y; Liu YH; Hu YY; Chen L; Li JM World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965 [TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling. Wang X; Chen Y; Liu W; Liu T; Sun D J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581 [TBL] [Abstract][Full Text] [Related]
10. Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness. Li Y; Wang D; Liu J; Li Y; Chen D; Zhou L; Lang T; Zhou Q Onco Targets Ther; 2020; 13():7151-7163. PubMed ID: 32801747 [TBL] [Abstract][Full Text] [Related]
11. Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells. Modarai SR; Opdenaker LM; Viswanathan V; Fields JZ; Boman BM BMC Cancer; 2016 Dec; 16(1):941. PubMed ID: 27927191 [TBL] [Abstract][Full Text] [Related]
12. CARMA3 Promotes Colorectal Cancer Cell Motility and Cancer Stemness via YAP-Mediated NF-κB Activation. Chang TY; Wu CT; Sheu ML; Yang RS; Liu SH Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885061 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Lombardo Y; Scopelliti A; Cammareri P; Todaro M; Iovino F; Ricci-Vitiani L; Gulotta G; Dieli F; de Maria R; Stassi G Gastroenterology; 2011 Jan; 140(1):297-309. PubMed ID: 20951698 [TBL] [Abstract][Full Text] [Related]
14. The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT Pathway. Sanches JGP; Song B; Zhang Q; Cui X; Yabasin IB; Ntim M; Li X; He J; Zhang Y; Mao J; Lu Y; Li L Front Oncol; 2021; 11():637298. PubMed ID: 33791221 [No Abstract] [Full Text] [Related]
15. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer. Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824 [TBL] [Abstract][Full Text] [Related]
16. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway. Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714 [TBL] [Abstract][Full Text] [Related]
17. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway. Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603 [TBL] [Abstract][Full Text] [Related]
18. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Wang J; Zhao H; Zheng L; Zhou Y; Wu L; Xu Y; Zhang X; Yan G; Sheng H; Xin R; Jiang L; Lei J; Zhang J; Chen Y; Peng J; Chen Q; Yang S; Yu K; Li D; Xie Q; Li Y Theranostics; 2021; 11(10):5045-5060. PubMed ID: 33754043 [No Abstract] [Full Text] [Related]
19. The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells. Fan F; Bellister S; Lu J; Ye X; Boulbes DR; Tozzi F; Sceusi E; Kopetz S; Tian F; Xia L; Zhou Y; Bhattacharya R; Ellis LM Br J Cancer; 2015 Feb; 112(3):539-46. PubMed ID: 25535733 [TBL] [Abstract][Full Text] [Related]
20. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling. Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]